Befus Deanna, Coeytaux Remy R, Goldstein Karen M, McDuffie Jennifer R, Shepherd-Banigan Megan, Goode Adam P, Kosinski Andrzej, Van Noord Megan G, Adam Soheir S, Masilamani Varsha, Nagi Avishek, Williams John W
1 Department of Family and Community Medicine, Center for Integrative Medicine , Wake Forest School of Medicine, Winston-Salem, NC.
2 Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center , Durham, NC.
J Altern Complement Med. 2018 Apr;24(4):314-323. doi: 10.1089/acm.2016.0408. Epub 2018 Jan 3.
Vasomotor symptoms (VMSs) are the most common symptoms reported during menopause. Although hormone therapy is effective for reducing VMSs, its use is restricted in some women. Many women with VMSs thus seek nonhormonal, nonpharmacologic treatment options such as acupuncture.
An umbrella systematic review (SR) was conducted, supplemented by a search of published randomized controlled trials (RCTs), that assessed the effectiveness of acupuncture for VMSs, health-related quality of life (HRQOL), and adverse effects of treatment in perimenopausal or postmenopausal women. Meta-analyses were conducted using a random-effects model when data were sufficient.
Three SRs and four new RCTs were identified that met eligibility criteria. Meta-analyses of this study revealed statistically significant standardized mean differences (SMDs) associated with acupuncture compared with no acupuncture at reducing VMS frequency (SMD -0.66, 95% confidence interval [CI] -1.06 to -0.26, I = 61.7%, 5 trials) and VMS severity (SMD -0.49, 95% CI -0.85 to -0.13, I = 18.1%, 4 trials) and improving HRQOL outcomes (SMD -0.93, 95% CI -1.20 to -0.67, I = 0.0%, 3 trials). SMDs were smaller or not statistically significant when acupuncture was compared with sham acupuncture.
Evidence from RCTs supports the use of acupuncture as an adjunctive or stand-alone treatment for reducing VMSs and improving HRQOL outcomes, with the caveat that observed clinical benefit associated with acupuncture may be due, in part, or in whole to nonspecific effects. The safety of acupuncture in the treatment of VMSs has not been rigorously examined, but there is no clear signal for a significant potential for harm.
血管舒缩症状(VMS)是绝经期间报告的最常见症状。尽管激素疗法对减轻VMS有效,但在某些女性中其使用受到限制。因此,许多有VMS的女性寻求非激素、非药物治疗选择,如针灸。
进行了一项伞形系统评价(SR),并辅以对已发表的随机对照试验(RCT)的检索,以评估针灸对围绝经期或绝经后女性VMS、健康相关生活质量(HRQOL)以及治疗不良反应的有效性。当数据足够时,使用随机效应模型进行荟萃分析。
确定了三项SR和四项符合纳入标准的新RCT。本研究的荟萃分析显示,与不进行针灸相比,针灸在降低VMS频率(标准化均数差[SMD] -0.66,95%置信区间[CI] -1.06至-0.26,I = 61.7%,5项试验)、VMS严重程度(SMD -0.49,95% CI -0.85至-0.13,I = 18.1%,4项试验)以及改善HRQOL结局(SMD -0.93,95% CI -1.20至-0.67,I = 0.0%,3项试验)方面具有统计学显著差异。与假针灸相比,针灸的SMD较小或无统计学显著差异。
RCT的证据支持将针灸作为减轻VMS和改善HRQOL结局的辅助或独立治疗方法,但需注意的是,观察到的与针灸相关的临床益处可能部分或全部归因于非特异性效应。针灸治疗VMS的安全性尚未经过严格检验,但尚无明显迹象表明存在重大潜在危害。